Close
New

Medscape is available in 5 Language Editions – Choose your Edition here.

 

Genetics of Methylmalonic Acidemia Workup

  • Author: Brendan Lee, MD, PhD; Chief Editor: Maria Descartes, MD  more...
 
Updated: Mar 16, 2015
 

Laboratory Studies

The reference ranges mentioned below may vary depending on the analytical method used.

Urine organic acids measured using gas chromatography–mass spectrometry (GC-MS) reveal large amounts of methylmalonic acid, methylcitrate, propionic acid, and 3-OH propionic acid.

Plasma amino acid measurements typically reveal elevated glycine levels. However, plasma glycine levels can also be within the reference range, even in an infant who previously had glycine levels outside of the reference range. The reference range is 100-390 mmol/L. Glycine may not be used as a metabolic marker.

Acylcarnitine profile (dry blood spot or plasma) reveals an elevation of propionylcarnitine (C3) levels and may reveal decreased free carnitine and total carnitine levels.

Total plasma homocysteine levels are assessed in cases of combined methylmalonic acidemia (MMA) and homocystinuria (cblC, cblD, and cblF forms of MMA). The reference range for all age groups is 2-14 mmol/L.

Plasma MMA levels are assayed for management. The reference range for all age groups is less than 0.2 mmol/L.

Plasma cobalamin levels are assessed, and the reference range is 130-785 pg/mL.

A CBC count is obtained to rule out macrocytic anemia, neutropenia, and thrombocytopenia.

Capillary blood gas is measured.

The reference range for ammonia levels in newborn infants is 90-150 mcg/dL. The reference range for infants aged 0-2 weeks is 79-130 mcg/dL. The reference range for those older than 1 month is 29-70 mcg/dL.

The reference range for blood glucose levels in full-term newborn infants is 45-120 mg/dL. The reference range for children is 60-105 mg/dL.

Plasma lactate is measured. The venous reference range is 5-20 mg/dL, and the arterial reference range is 5-14 mg/dL.

Electrolyte levels are also obtained.

Plasma uric acid levels are obtained. The reference range for those aged 0-2 years is 2.4-6.4 mg/dL. The reference range for children aged 2-12 years is 2.4-5.9 mg/dL.

The reference range for plasma creatinine for newborn infants is 0.6-1.2 mg/dL. The reference range for infants is 0.2-0.4 mg/dL, and the reference range for children is 0.3-0.7 mg/dL.

The reference range for plasma urea is 5-21 mg/dL.

The GFR is measured in older children, and the reference range for newborn infants is 40-65 mL/min/1.73 m2. The reference range for children older than 1 year is 98-150 mL/min/1.73 m2.

Prenatal diagnosis is possible by measuring activity of methylmalonyl-CoA mutase in cultured amniocytes.

Next

Imaging Studies

Brain CT scanning and MRI typically reveal involvement of basal ganglia and white matter.

Previous
Next

Other Tests

The advent of next-generation sequencing has given rise to panels of DNA tests that can test for many of the genes at once. These panels offer high sensitivity and specificity, although they may miss duplication or deletion of parts of a specific gene. Here, targeted array comparative hybridization with coverage of specific genes is used. Finally, clinical whole-exome sequencing may offer the potential to identify oligogenic causes and/or new genetic causes of MMA.

Previous
 
 
Contributor Information and Disclosures
Author

Brendan Lee, MD, PhD Professor, Robert and Janice McNair Endowed Chair in Molecular and Human Genetics, Department of Molecular and Human Genetics, Baylor College of Medicine

Brendan Lee, MD, PhD is a member of the following medical societies: American Academy of Pediatrics, American College of Medical Genetics and Genomics, Society for Pediatric Research

Disclosure: Serve(d) as a director, officer, partner, employee, advisor, consultant or trustee for: Biomarin; Retrophin;.

Coauthor(s)

Olaf A Bodamer, MD, PhD, FAAP, FACMG Park Gerald Chair in Genetics and Genomics, Associate Chief, Division of Genetics and Genomics, Department of Medicine, Boston Children's Hospital, Harvard Medical School

Olaf A Bodamer, MD, PhD, FAAP, FACMG is a member of the following medical societies: American Medical Association, American Society of Human Genetics

Disclosure: Nothing to disclose.

Specialty Editor Board

Mary L Windle, PharmD Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Chief Editor

Maria Descartes, MD Professor, Department of Human Genetics and Department of Pediatrics, University of Alabama at Birmingham School of Medicine

Maria Descartes, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Medical Genetics and Genomics, American Medical Association, American Society of Human Genetics, Society for Inherited Metabolic Disorders, International Skeletal Dysplasia Society, Southeastern Regional Genetics Group

Disclosure: Nothing to disclose.

Additional Contributors

Christian J Renner, MD Consulting Staff, Department of Pediatrics, University Hospital for Children and Adolescents, Erlangen, Germany

Disclosure: Nothing to disclose.

References
  1. Oberholzer VG, Levin B, Burgess EA, Young WF. Methylmalonic aciduria. An inborn error of metabolism leading to chronic metabolic acidosis. Arch Dis Child. 1967 Oct. 42(225):492-504. [Medline].

  2. Stokke O, Jellum E, Eldjarn L, Schnitler R. The occurrence of beta-hydroxy-n-valeric acid in a patient with propionic and methylmalonic acidemia. Clin Chim Acta. 1973 May 30. 45(4):391-401. [Medline].

  3. Ledley FD, Jansen R, Nham SU, Fenton WA, Rosenberg LE. Mutation eliminating mitochondrial leader sequence of methylmalonyl-CoA mutase causes muto methylmalonic acidemia. Proc Natl Acad Sci U S A. 1990 Apr. 87(8):3147-50. [Medline]. [Full Text].

  4. Bikker H, Bakker HD, Abeling NG, Poll-The BT, Kleijer WJ, Rosenblatt DS, et al. A homozygous nonsense mutation in the methylmalonyl-CoA epimerase gene (MCEE) results in mild methylmalonic aciduria. Hum Mutat. 2006 Jul. 27(7):640-3. [Medline].

  5. Dempsey-Nunez L, Illson ML, Kent J, Huang Q, Brebner A, Watkins D, et al. High resolution melting analysis of the MMAA gene in patients with cblA and in those with undiagnosed methylmalonic aciduria. Mol Genet Metab. 2012 Nov. 107(3):363-7. [Medline].

  6. Girisha KM, Shrikiran A, Bidchol AM, Sakamoto O, Gopinath PM, Satyamoorthy K. Novel mutation in an Indian patient with Methylmalonic Acidemia, cblA type. Indian J Hum Genet. 2012 Sep. 18(3):346-8. [Medline]. [Full Text].

  7. Dündar H, Özgül RK, Güzel-Ozantürk A, Dursun A, Sivri S, Aliefendioglu D, et al. Microarray based mutational analysis of patients with methylmalonic acidemia: identification of 10 novel mutations. Mol Genet Metab. 2012 Aug. 106(4):419-23. [Medline].

  8. Dobson CM, Wai T, Leclerc D, Wilson A, Wu X, Doré C, et al. Identification of the gene responsible for the cblA complementation group of vitamin B12-responsive methylmalonic acidemia based on analysis of prokaryotic gene arrangements. Proc Natl Acad Sci U S A. 2002 Nov 26. 99(24):15554-9. [Medline]. [Full Text].

  9. Dobson CM, Wai T, Leclerc D, Kadir H, Narang M, Lerner-Ellis JP, et al. Identification of the gene responsible for the cblB complementation group of vitamin B12-dependent methylmalonic aciduria. Hum Mol Genet. 2002 Dec 15. 11(26):3361-9. [Medline].

  10. Lerner-Ellis JP, Anastasio N, Liu J, Coelho D, Suormala T, Stucki M, et al. Spectrum of mutations in MMACHC, allelic expression, and evidence for genotype-phenotype correlations. Hum Mutat. 2009 Jul. 30(7):1072-81. [Medline].

  11. Coelho D, Suormala T, Stucki M, Lerner-Ellis JP, Rosenblatt DS, Newbold RF, et al. Gene identification for the cblD defect of vitamin B12 metabolism. N Engl J Med. 2008 Apr 3. 358(14):1454-64. [Medline].

  12. Rutsch F, Gailus S, Miousse IR, Suormala T, Sagné C, Toliat MR, et al. Identification of a putative lysosomal cobalamin exporter altered in the cblF defect of vitamin B12 metabolism. Nat Genet. 2009 Feb. 41(2):234-9. [Medline].

  13. Coelho D, Kim JC, Miousse IR, Fung S, du Moulin M, Buers I, et al. Mutations in ABCD4 cause a new inborn error of vitamin B12 metabolism. Nat Genet. 2012 Oct. 44(10):1152-5. [Medline].

  14. Sloan JL, Johnston JJ, Manoli I, et al. Exome sequencing identifies ACSF3 as a cause of combined malonic and methylmalonic aciduria. Nat Genet. 2011 Aug 14. 43(9):883-6. [Medline]. [Full Text].

  15. Coulombe JT, Shih VE, Levy HL. Massachusetts Metabolic Disorders Screening Program. II. Methylmalonic aciduria. Pediatrics. 1981 Jan. 67(1):26-31. [Medline].

  16. Lerner-Ellis JP, Tirone JC, Pawelek PD, et al. Identification of the gene responsible for methylmalonic aciduria and homocystinuria, cblC type. Nat Genet. 2006 Jan. 38(1):93-100. [Medline].

  17. Acquaviva C, Benoist JF, Pereira S, et al. Molecular basis of methylmalonyl-CoA mutase apoenzyme defect in 40 European patients affected by mut(o) and mut- forms of methylmalonic acidemia: identification of 29 novel mutations in the MUT gene. Hum Mutat. 2005 Feb. 25(2):167-76. [Medline].

  18. Andersson HC, Shapira E. Biochemical and clinical response to hydroxocobalamin versus cyanocobalamin treatment in patients with methylmalonic acidemia and homocystinuria (cblC). J Pediatr. 1998 Jan. 132(1):121-4. [Medline].

  19. Caksen H, Atas B, Tuncer O, Odabas D. Severe generalized dystonia induced by metoclopramide in a girl with methylmalonic acidemia. Brain Dev. 2003 Mar. 25(2):144-5. [Medline].

  20. Dobson CM, Wai T, Leclerc D, et al. Identification of the gene responsible for the cblA complementation group of vitamin B12-responsive methylmalonic acidemia based on analysis of prokaryotic gene arrangements. Proc Natl Acad Sci U S A. 2002 Nov 26. 99(24):15554-9. [Medline].

  21. Fenton WA, Rosenberg LE. Disorders of propionate and methylmalonate metabolism. Scriver CR, Beaudet AL, Sly WS, Valle DL, eds. The Metabolic and Molecular Bases of Inherited Disease. New York, NY: McGraw-Hill Co; 1995. 1423-49.

  22. Fowler B. Genetic defects of folate and cobalamin metabolism. Eur J Pediatr. 1998 Apr. 157 Suppl 2:S60-6. [Medline].

  23. Huemer M, Simma B, Fowler B, et al. Prenatal and postnatal treatment in cobalamin C defect. J Pediatr. 2005 Oct. 147(4):469-72. [Medline].

  24. Morel CF, Watkins D, Scott P, et al. Prenatal diagnosis for methylmalonic acidemia and inborn errors of vitamin B12 metabolism and transport. Mol Genet Metab. 2005 Sep-Oct. 86(1-2):160-71. [Medline].

  25. Nyhan WL. Methylmalonic acidemia. Atlas of Metabolic Diseases. New York, NY: Chapman & Hall Medical; 1998. 13-23.

  26. Ostergaard E, Wibrand F, Orngreen MC, et al. Impaired energy metabolism and abnormal muscle histology in mut- methylmalonic aciduria. Neurology. 2005 Sep 27. 65(6):931-3. [Medline].

  27. Rosenblatt DS, Whitehead VM. Cobalamin and folate deficiency: acquired and hereditary disorders in children. Semin Hematol. 1999 Jan. 36(1):19-34. [Medline].

  28. Tanpaiboon P. Methylmalonic acidemia (MMA). Mol Genet Metab. 2005 May. 85(1):2-6. [Medline].

  29. Worgan LC, Niles K, Tirone JC, et al. Spectrum of mutations in mut methylmalonic acidemia and identification of a common Hispanic mutation and haplotype. Hum Mutat. 2006 Jan. 27(1):31-43. [Medline].

 
Previous
Next
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.